Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Grayson Hatfield, Lioudmila Tepliakova, Jessica Tran, Huixin Lu, Michel Gilbert & Roger Y. Tam. (2023) Bivalent non-human gal-α1-3-gal glycan epitopes in the Fc region of a monoclonal antibody model can be recognized by anti-Gal-α1-3-Gal IgE antibodies. mAbs 15:1.
Read now
Read now
Jéssica M. Sá, João V. Piloto, Eduardo M. Cilli, Ljubica Tasic, Marcelo A. Fossey, Fábio C. L. Almeida, Fátima P. Souza & Ícaro P. Caruso. (2022) Hesperetin targets the hydrophobic pocket of the nucleoprotein/phosphoprotein binding site of human respiratory syncytial virus. Journal of Biomolecular Structure and Dynamics 40:5, pages 2156-2168.
Read now
Read now
Natividad Viguria, Ana Navascués, Regina Juanbeltz, Alberto Echeverría, Carmen Ezpeleta & Jesús Castilla. (2021) Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children. Human Vaccines & Immunotherapeutics 17:6, pages 1867-1872.
Read now
Read now
Masato Takeuchi & Koji Kawakami. (2021) Universal palivizumab prophylaxis for children with Down syndrome in Japan: analysis with interrupted time-series. Human Vaccines & Immunotherapeutics 17:4, pages 1235-1238.
Read now
Read now
Harrison C. Bergeron & Ralph A. Tripp. (2020) Emerging small and large molecule therapeutics for respiratory syncytial virus. Expert Opinion on Investigational Drugs 29:3, pages 285-294.
Read now
Read now
Fu-Shi Quan, Swarnendu Basak, Ki-Back Chu, Sung Soo Kim & Sang-Moo Kang. (2020) Progress in the development of virus-like particle vaccines against respiratory viruses. Expert Review of Vaccines 19:1, pages 11-24.
Read now
Read now
Articles from other publishers (83)
Felipe Teixeira de Mello Freitas, Cíntia Costa Pereira Pimentel, Pedro Ribeiro Bianchini, Rafaela Moreira de Carvalho, Alexandre Peixoto Serafim & Cira Ferreira Antunes Costa. (2024) Evaluation of Severe Acute Respiratory Syndrome surveillance caused by respiratory viruses in a pediatric unit, 2013 to 2019. Revista Paulista de Pediatria 42.
Crossref
Crossref
Rutger M. Schepp, Joanna Kaczorowska, Pieter G. M. van Gageldonk, Elsbeth D. M. Rouers, Elisabeth A. M. Sanders, Patricia C. J. Bruijning-Verhagen & Guy A. M. Berbers. (2023) Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands. Vaccines 11:12, pages 1807.
Crossref
Crossref
Hasindu S. Edirisinghe, Anushi E. Rajapaksa, Simon G. Royce, Magdy Sourial, Robert J. Bischof, Jeremy Anderson, Gulcan Sarila, Cattram D. Nguyen, Kim Mulholland, Lien Anh Ha Do & Paul V. Licciardi. (2023) Aerosol Delivery of Palivizumab in a Neonatal Lamb Model of Respiratory Syncytial Virus Infection. Viruses 15:11, pages 2276.
Crossref
Crossref
Julia Ettich, Christoph Wittich, Jens M. Moll, Kristina Behnke, Doreen M. Floss, Jens Reiners, Andreas Christmann, Philipp A. Lang, Sander H.J. Smits, Harald Kolmar & Jürgen Scheller. (2023) Respiratory syncytial virus–approved mAb Palivizumab as ligand for anti-idiotype nanobody-based synthetic cytokine receptors. Journal of Biological Chemistry 299:11, pages 105270.
Crossref
Crossref
Li-Ching Fang, Jen-Yu Wang, Hsin-Hui Yu, Li-Chieh Wang & Bor-Luen Chiang. (2023) Respiratory-syncytial virus immunoprophylaxis on asthma symptoms development in prematurity with bronchopulmonary dysplasia. Journal of Allergy and Clinical Immunology: Global 2:4, pages 100161.
Crossref
Crossref
Sharon L Sanders, Sushil Agwan, Mohamed Hassan, Louis J Bont & Roderick P Venekamp. (2023) Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection. Cochrane Database of Systematic Reviews 2023:10.
Crossref
Crossref
Eilish Moore & Mary Hughes. (2023) Respiratory syncytial virus and its prophylaxis with palivizumab: exploring nurses’ knowledge. Nursing Children and Young People 35:5, pages 14-21.
Crossref
Crossref
Ali Mahmoudi, Seyedeh Hoda Alavizadeh, Seyedeh Atefeh Hosseini, Pouria Meidany, Maham Doagooyan, Yasaman Abolhasani, Zakieh Saadat, Fatemeh Amani, Prashant Kesharwani, Fatemeh Gheybi & Amirhossein Sahebkar. (2023) Harnessing aptamers against COVID-19: A therapeutic strategy. Drug Discovery Today 28:8, pages 103663.
Crossref
Crossref
Burcu Özkan, Ebru Altuntaş, Ümmühan Ünlü, Hasan Hüseyin Doğan, Yıldız Özsoy & Rabia Çakır Koç. (2023) Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus. Pharmaceutics 15:8, pages 2055.
Crossref
Crossref
Abbie Oey, Matthew McClure, Julian A. Symons, Sushmita Chanda, John Fry, Patrick F. Smith, Kathia Luciani, Michael Fayon, Kulkanya Chokephaibulkit, Rattapon Uppala, Jolanta Bernatoniene, Kenji Furuno, Thorsten Stanley, Dymphy Huntjens & James Witek. (2023) Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results. PLOS ONE 18:7, pages e0288271.
Crossref
Crossref
Marina Antillón, Xiao Li, Lander Willem, Joke Bilcke, Mark Jit & Philippe Beutels. (2023) The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach. PLOS Medicine 20:7, pages e1004250.
Crossref
Crossref
Jimin Xu, Yu Xue, Andrew A. Bolinger, Jun Li, Mingxiang Zhou, Haiying Chen, Hongmin Li & Jia Zhou. (2023) Therapeutic potential of salicylamide derivatives for combating viral infections. Medicinal Research Reviews 43:4, pages 897-931.
Crossref
Crossref
Xiaomin Dong, Yi-Mo Deng, Ammar Aziz, Paul Whitney, Julia Clark, Patrick Harris, Catherine Bautista, Anna-Maria Costa, Gregory Waller, Andrew J Daley, Megan Wieringa, Tony Korman & Ian G. Barr. (2023) A simplified, amplicon-based method for whole genome sequencing of human respiratory syncytial viruses. Journal of Clinical Virology 161, pages 105423.
Crossref
Crossref
Niamh M. O’Boyle, Jean-Jacques Helesbeux, Mary J. Meegan, Astrid Sasse, Elizabeth O’Shaughnessy, Alina Qaisar, Aoife Clancy, Florence McCarthy & Pascal Marchand. (2023) 30th Annual GP2A Medicinal Chemistry Conference. Pharmaceuticals 16:3, pages 432.
Crossref
Crossref
Chee Mun Chan, Asrul Abdul Wahab & Adli Ali. (2023) Determining the Relationship of Meteorological Factors and Severe Pediatric Respiratory Syncytial Virus (RSV) Infection in Central Peninsular Malaysia. International Journal of Environmental Research and Public Health 20:3, pages 1848.
Crossref
Crossref
Geetika Arora, Shreya Gupta & Daman Saluja. 2023. Emerging Human Viral Diseases, Volume I. Emerging Human Viral Diseases, Volume I
587
618
.
Marco Heppe-Montero, Stefan Walter, Valentín Hernández-Barrera, Ruth Gil-Prieto & Ángel Gil-de-Miguel. (2022) Burden of respiratory syncytial virus-associated lower respiratory infections in children in Spain from 2012 to 2018. BMC Infectious Diseases 22:1.
Crossref
Crossref
Paolo Manzoni, Eugenio Baraldi, Manuel Sánchez Luna & Chryssoula Tzialla. (2022) Real-World Studies of Respiratory Syncytial Virus Hospitalizations among Moderate/Late Preterm Infants Exposed to Passive Immunoprophylaxis with Palivizumab. American Journal of Perinatology 39:S 01, pages S7-S13.
Crossref
Crossref
Ian Mitchell, Abby Li, Candice L. Bjornson, Krista L. Lanctot & Bosco A. Paes. (2021) Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada. American Journal of Perinatology 39:15, pages 1668-1677.
Crossref
Crossref
Bahaa Abu-Raya, Frederic Reicherz & Pascal M. Lavoie. (2022) Correlates of Protection Against Respiratory Syncytial Virus Infection in Infancy. Clinical Reviews in Allergy & Immunology 63:3, pages 371-380.
Crossref
Crossref
Sara Pischedda, Irene Rivero-Calle, Alberto Gómez-Carballa, Miriam Cebey-López, Ruth Barral-Arca, Jose Gómez-Rial, Jacobo Pardo-Seco, María-José Curras-Tuala, Sandra Viz-Lasheras, Xabier Bello, Ana B. Crujeiras, Angel Diaz-Lagares, María Teresa González-López, Federico Martinón-Torres & Antonio Salas. (2022) Role and Diagnostic Performance of Host Epigenome in Respiratory Morbidity after RSV Infection: The EPIRESVi Study. Frontiers in Immunology 13.
Crossref
Crossref
Diana Canals Hernaez, Michael R. Hughes, Yicong Li, Ilaria Mainero Rocca, Pamela Dean, Julyanne Brassard, Erin M. Bell, Ismael Samudio, Anne-Marie Mes-Masson, Yoshiki Narimatsu, Henrik Clausen, Ola Blixt, Calvin D. Roskelley & Kelly M. McNagny. (2022) Targeting a Tumor-Specific Epitope on Podocalyxin Increases Survival in Human Tumor Preclinical Models. Frontiers in Oncology 12.
Crossref
Crossref
Marco Mesa-FriasCarmine RossiBruno EmondBrahim BookhartDavid AndersonSherine DrummondJingru WangPatrick LefebvreLois E LameratoMarie-Hélène Lafeuille. (2022) Incidence and economic burden of respiratory syncytial virus among adults in the United States: A retrospective analysis using 2 insurance claims databases. Journal of Managed Care & Specialty Pharmacy, pages 1-13.
Crossref
Crossref
Ana M. Nuñez Castrejon, Sara M. O’Rourke, Lawrence M. Kauvar & Rebecca M. DuBois. (2022) Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens. Journal of Virology 96:7.
Crossref
Crossref
Shilu Mathew, Sara Taleb, Ali Hussein Eid, Asmaa A. Althani & Hadi M. Yassine. (2021) In silico virtual screening of lead compounds for major antigenic sites in respiratory syncytial virus fusion protein. Emergent Materials 5:2, pages 295-305.
Crossref
Crossref
Koo Nagasawa & Naruhiko Ishiwada. (2022) Disease burden of respiratory syncytial virus infection in the pediatric population in Japan. Journal of Infection and Chemotherapy 28:2, pages 146-157.
Crossref
Crossref
P. Pandiaraja, S. Aishwarya, S. V. Indubala, S. Neethiga & K. Sanjana. 2022. Applied Computational Technologies. Applied Computational Technologies
742
754
.
Halie M. Rando, Nils Wellhausen, Soumita Ghosh, Alexandra J. Lee, Anna Ada Dattoli, Fengling Hu, James Brian Byrd, Diane N. Rafizadeh, Ronan Lordan, Yanjun Qi, Yuchen Sun, Christian Brueffer, Jeffrey M. Field, Marouen Ben Guebila, Nafisa M. Jadavji, Ashwin N. Skelly, Bharath Ramsundar, Jinhui Wang, Rishi Raj Goel, YoSon Park, Simina M. Boca, Anthony Gitter & Casey S. Greene. (2021) Identification and Development of Therapeutics for COVID-19. mSystems 6:6.
Crossref
Crossref
Harrison C. Bergeron & Ralph A. Tripp. (2021) Immunopathology of RSV: An Updated Review. Viruses 13:12, pages 2478.
Crossref
Crossref
Abu Hamza, Abdus Samad, Md. Ali Imam, Md. Imam Faizan, Anwar Ahmed, Fahad N. Almajhdi, Tajamul Hussain, Asimul Islam & Shama Parveen. (2021) Structural Characterization of Ectodomain G Protein of Respiratory Syncytial Virus and Its Interaction with Heparan Sulfate: Multi-Spectroscopic and In Silico Studies Elucidating Host-Pathogen Interactions. Molecules 26:23, pages 7398.
Crossref
Crossref
Guohong Zhu, Dan Xu, Yuanyuan Zhang, Tianlin Wang, Lingyan Zhang, Weizhong Gu & Meiping Shen. (2021) Epidemiological characteristics of four common respiratory viral infections in children. Virology Journal 18:1.
Crossref
Crossref
Liliya Vakrilova, Stanislava Hitrova Nikolova, Sergei Slavov, Petya Radulova & Boryana Slancheva. (2021) An outbreak of RSV infections in a neonatology clinic during the RSV-season. BMC Pediatrics 21:1.
Crossref
Crossref
Junping Ren, Wenzhe Wu, Ke Zhang, Eun-Jin Choi, Pingyuan Wang, Teodora Ivanciuc, Alex Peniche, Youwen Qian, Roberto P. Garofalo, Jia Zhou & Xiaoyong Bao. (2021) Exchange Protein Directly Activated by cAMP 2 Enhances Respiratory Syncytial Virus-Induced Pulmonary Disease in Mice. Frontiers in Immunology 12.
Crossref
Crossref
Guangjin Xun, Xingpan Song, Jie Hu, Haiwei Zhang, Lan Liu, Zhe Zhang & Rui Gong. (2021) Potent Human Single-Domain Antibodies Specific for a Novel Prefusion Epitope of Respiratory Syncytial Virus F Glycoprotein. Journal of Virology 95:18.
Crossref
Crossref
Eun-Jin Choi, Wenzhe Wu, Xiaoyan Cong, Ke Zhang, Jiaqi Luo, Sha Ye, Pingyuan Wang, Adarsh Suresh, Uneeb Mohammad Ullah, Jia Zhou & Xiaoyong Bao. (2021) Broad Impact of Exchange Protein Directly Activated by cAMP 2 (EPAC2) on Respiratory Viral Infections. Viruses 13:6, pages 1179.
Crossref
Crossref
Zachary A. Schiller, Michael J. Rudolph, Jacqueline R. Toomey, Monir Ejemel, Alan LaRochelle, Simon A. Davis, Havard S. Lambert, Aurélie Kern, Amanda C. Tardo, Colby A. Souders, Eric Peterson, Rebecca D. Cannon, Chandrashekar Ganesa, Frank Fazio, Nicholas J. Mantis, Lisa A. Cavacini, John Sullivan-Bolyai, Linden T. Hu, Monica E. Embers, Mark S. Klempner & Yang Wang. (2021) Blocking Borrelia burgdorferi transmission from infected ticks to nonhuman primates with a human monoclonal antibody. Journal of Clinical Investigation 131:11.
Crossref
Crossref
Jimin Xu, Wenzhe Wu, Haiying Chen, Yu Xue, Xiaoyong Bao & Jia Zhou. (2021) Substituted N-(4-amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues potently inhibit respiratory syncytial virus (RSV) replication and RSV infection-associated inflammatory responses. Bioorganic & Medicinal Chemistry 39, pages 116157.
Crossref
Crossref
Xianbang Hou, Xueyuan Zhang, Jingting Bi, Anhong Zhu & Liwei He. (2021) Indole-3-carboxaldehyde regulates RSV-induced inflammatory response in RAW264.7 cells by moderate inhibition of the TLR7 signaling pathway. Journal of Natural Medicines 75:3, pages 602-611.
Crossref
Crossref
Caroline M. Sierra, Alice Park, Eunsi Eum, Giselle Garcia, Mireya Lopez, Shawnée N. Daniel, Khaled Bahjri & Kristine A. Parbuoni. (2020) Adherence to the 2014 American Academy of Pediatrics palivizumab prophylaxis recommendations. Pediatric Pulmonology 56:5, pages 1121-1126.
Crossref
Crossref
Arturo Casadevall, Liise-anne Pirofski & Michael J. Joyner. (2021) The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19. mBio 12:2.
Crossref
Crossref
Merricka C. Livingstone, Alexis A. Bitzer, Alish Giri, Kun Luo, Rajeshwer S. Sankhala, Misook Choe, Xiaoyan Zou, S. Moses Dennison, Yuanzhang Li, William Washington, Viseth Ngauy, Georgia D. Tomaras, M. Gordon Joyce, Adrian H. Batchelor & Sheetij Dutta. (2021) In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP). Scientific Reports 11:1.
Crossref
Crossref
Archana Chatterjee, Kunjana Mavunda & Leonard R. Krilov. (2021) Current State of Respiratory Syncytial Virus Disease and Management. Infectious Diseases and Therapy 10:S1, pages 5-16.
Crossref
Crossref
Leonard R. Krilov, Joseph B. Domachowske & Evan J. Anderson. (2021) RSV Disease: Current Management and the Future of Treatment and Prevention. Infectious Diseases and Therapy 10:S1, pages 1-3.
Crossref
Crossref
Joseph B. Domachowske, Evan J. Anderson & Mitchell Goldstein. (2021) The Future of Respiratory Syncytial Virus Disease Prevention and Treatment. Infectious Diseases and Therapy 10:S1, pages 47-60.
Crossref
Crossref
Harrison C. Bergeron, Jackelyn Murray, Ana M. Nuñez Castrejon, Rebecca M. DuBois & Ralph A. Tripp. (2021) Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies. Viruses 13:2, pages 352.
Crossref
Crossref
Steven J. Frey, Chad Varner, Ammar Arsiwala, Michael G. Currier, Martin L. Moore & Ravi S. Kane. (2020) The Design of Vaccines Based on the Shielding of Antigenic Site Ø of a Respiratory Syncytial Virus Fusion Protein Immunogen. Advanced Healthcare Materials 10:4.
Crossref
Crossref
Cailin E. Deal, Andrea Carfi & Obadiah J. Plante. (2021) Advancements in mRNA Encoded Antibodies for Passive Immunotherapy. Vaccines 9:2, pages 108.
Crossref
Crossref
Chao Zhang, Yifan Wang, Yuanfei Zhu, Caixuan Liu, Chenjian Gu, Shiqi Xu, Yalei Wang, Yu Zhou, Yanxing Wang, Wenyu Han, Xiaoyu Hong, Yong Yang, Xueyang Zhang, Tingfeng Wang, Cong Xu, Qin Hong, Shutian Wang, Qiaoyu Zhao, Weihua Qiao, Jinkai Zang, Liangliang Kong, Fangfang Wang, Haikun Wang, Di Qu, Dimitri Lavillette, Hong Tang, Qiang Deng, Youhua Xie, Yao Cong & Zhong Huang. (2021) Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections. Nature Communications 12:1.
Crossref
Crossref
Joseph B Domachowske. (2021) Nirsevimab: An Extended Half-life Monoclonal Antibody for the Prevention of Infant Respiratory Syncytial Virus Infection. US Respiratory & Pulmonary Diseases 6:1, pages 38.
Crossref
Crossref
Bahaa Abu-Raya & Kirsten Maertens. (2021) Protection of the Newborn Through Vaccination in Pregnancy. NeoReviews 22:1, pages e25-e39.
Crossref
Crossref
. 2021. ERS Handbook of Paediatric Respiratory Medicine. ERS Handbook of Paediatric Respiratory Medicine
244
347
.
Nazia Thakur, Carina Conceicao, Ariel Isaacs, Stacey Human, Naphak Modhiran, Rebecca K. McLean, Miriam Pedrera, Tiong Kit Tan, Pramila Rijal, Alain Townsend, Geraldine Taylor, Paul R. Young, Daniel Watterson, Keith J. Chappell, Simon P. Graham & Dalan Bailey. (2021) Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell–cell fusion. Journal of General Virology 102:1.
Crossref
Crossref
Akiko Kamori, Yuya Morooka, Kenichiro Yamamura, Pin Fee Chong, Noriko Kuga, Yasushi Takahata, Koichi Sagawa & Kenji Furuno. (2021) Effect of delayed palivizumab administration on respiratory syncytial virus infection-related hospitalisation. Medicine 100:47, pages e27952.
Crossref
Crossref
Leyla Asadi & Giovanni Ferrara. 2021. Encyclopedia of Virology. Encyclopedia of Virology
267
280
.
Lauren Alexandra Quinn, Michael D. Shields, Ian Sinha & Helen E. Groves. (2020) Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a systematic review. Systematic Reviews 9:1.
Crossref
Crossref
Carlotta Biagi, Arianna Dondi, Sara Scarpini, Alessandro Rocca, Silvia Vandini, Giulia Poletti & Marcello Lanari. (2020) Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines. Vaccines 8:4, pages 672.
Crossref
Crossref
MengJie Hu, Marie A. Bogoyevitch & David A. Jans. (2020) Impact of Respiratory Syncytial Virus Infection on Host Functions: Implications for Antiviral Strategies. Physiological Reviews 100:4, pages 1527-1594.
Crossref
Crossref
Fatiha Najioullah, Pierre Bancons, Raymond Césaire & Olivier Fléchelles. (2020) Seasonality and coinfection of bronchiolitis: epidemiological specificity and consequences in terms of prophylaxis in tropical climate. Tropical Medicine & International Health 25:10, pages 1291-1297.
Crossref
Crossref
Simone Filardo, Marisa Di Pietro, Paola Mastromarino & Rosa Sessa. (2020) Therapeutic potential of resveratrol against emerging respiratory viral infections. Pharmacology & Therapeutics 214, pages 107613.
Crossref
Crossref
Eugenio Baraldi, Luca Bonadies & Paolo Manzoni. (2020) Evidence on the Link between Respiratory Syncytial Virus Infection in Early Life and Chronic Obstructive Lung Diseases. American Journal of Perinatology 37:S 02, pages S26-S30.
Crossref
Crossref
Baidya Nath P. Sah, Jiraporn Lueangsakulthai, Bum Jin Kim, Benjamin R. Hauser, Yeonhee Woo, Amy Olyaei, Molly Aloia, Ann O'Connor, Brian Scottoline, Manoj K. Pastey & David C. Dallas. (2020) Partial Degradation of Recombinant Antibody Functional Activity During Infant Gastrointestinal Digestion: Implications for Oral Antibody Supplementation. Frontiers in Nutrition 7.
Crossref
Crossref
Leonard R. Krilov & Evan J. Anderson. (2020) Respiratory syncytial virus hospitalizations in US preterm infants after the 2014 change in immunoprophylaxis guidance by the American Academy of Pediatrics. Journal of Perinatology 40:8, pages 1135-1144.
Crossref
Crossref
Juilee Thakar, Yu Qian, Lauren Benoodt, David Roumanes, Xing Qiu, Nathan Laniewski, ChinYi Chu, Christopher Slaunwhite, Lu Wang, Aishwarya Mandava, Ivan Chang, Ann R. Falsey, Mary T. Caserta, Thomas J. Mariani, Richard H. Scheuermann, Edward E. Walsh & David J. Topham. (2020) Unbiased analysis of peripheral blood mononuclear cells reveals CD4 T cell response to RSV matrix protein. Vaccine: X 5, pages 100065.
Crossref
Crossref
Aharona Glatman-Freedman, Zalman Kaufman, Yael Applbaum, Rita Dichtiar, Ada Steiman, Ethel-Sherry Gordon, Lital Keinan-Boker, Tamy Shohat & Ziona Haklai. (2020) Respiratory Syncytial Virus hospitalization burden: a nation-wide population-based analysis, 2000-2017. Journal of Infection 81:2, pages 297-303.
Crossref
Crossref
Bahaa Abu-Raya, Kirsten Maertens, Kathryn M. Edwards, Saad B. Omer, Janet A. Englund, Katie L. Flanagan, Matthew D. Snape, Gayatri Amirthalingam, Elke Leuridan, Pierre Van Damme, Vana Papaevangelou, Odile Launay, Ron Dagan, Magda Campins, Anna Franca Cavaliere, Tiziana Frusca, Sofia Guidi, Miguel O'Ryan, Ulrich Heininger, Tina Tan, Ahmed R. Alsuwaidi, Marco. A. Safadi, Luz M. Vilca, Nasamon Wanlapakorn, Shabir A. Madhi, Michelle L. Giles, Roman Prymula, Shamez Ladhani, Federico Martinón-Torres, Litjen Tan, Lessandra Michelin, Giovanni Scambia, Nicola Principi & Susanna Esposito. (2020) Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement. Frontiers in Immunology 11.
Crossref
Crossref
Askin Gülsen, Bettina Wedi & Uta Jappe. (2020) Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in complex immune-derived adverse events. Allergo Journal International 29:4, pages 97-125.
Crossref
Crossref
Askin Gülsen, Bettina Wedi & Uta Jappe. (2020) Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in complex immune-derived adverse events*. Allergo Journal 29:4, pages 32-61.
Crossref
Crossref
Lauren Alexandra Quinn, Michael D. Shields & Helen E. Groves. (2019) Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a protocol for a systematic review. Systematic Reviews 8:1.
Crossref
Crossref
B. Resch, E. Eber, D. Ehringer-Schetitska, U. Kiechl-Kohlendorfer, I. Michel‑Behnke, T. Popow-Kraupp, M. Redlberger-Fritz, M. Seidel, V. Strenger, M. Wald, A. Zacharasiewicz & A. Berger. (2019) Respiratory-Syncytial-Virus-Prophylaxe mit PalivizumabRespiratory Syncytial Virus Prophylaxis with Palivizumab. Pädiatrie & Pädologie 54:6, pages 270-276.
Crossref
Crossref
MengJie Hu, Marie A. Bogoyevitch & David A. Jans. (2019) Subversion of Host Cell Mitochondria by RSV to Favor Virus Production is Dependent on Inhibition of Mitochondrial Complex I and ROS Generation. Cells 8:11, pages 1417.
Crossref
Crossref
Maja Daurach & Ina Michel-Behnke. 2019. The Burden of Respiratory Syncytial Virus Infection in the Young. The Burden of Respiratory Syncytial Virus Infection in the Young.
Miriam Dibo, Eduardo C. Battocchio, Lucas M. dos Santos Souza, Matheus D. Veloso da Silva, Bruna K. Banin-Hirata, Milena M.M. Sapla, Poliana Marinello, Sérgio P.D. Rocha & Lígia C. Faccin-Galhardi. (2019) Antibody Therapy for the Control of Viral Diseases: An Update. Current Pharmaceutical Biotechnology 20:13, pages 1108-1121.
Crossref
Crossref
Robin D.V. Kleinert, Eduardo Montoya-Diaz, Tanvi Khera, Kathrin Welsch, Birthe Tegtmeyer, Sebastian Hoehl, Sandra Ciesek & Richard J.P. Brown. (2019) Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus. Viruses 11:10, pages 960.
Crossref
Crossref
Lydia J. Atherton, Patricia A. Jorquera, Abhijeet A. Bakre & Ralph A. Tripp. (2019) Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types. Frontiers in Immunology 10.
Crossref
Crossref
Florence Chau-Etchepare, Joshua L Hoerger, Brooks T Kuhn, Amir A Zeki, Angela Haczku, Samuel Louie, Nicholas J Kenyon, Cristina E Davis & Michael Schivo. (2023) Viruses and non-allergen environmental triggers in asthma. Journal of Investigative Medicine 67:7, pages 1029-1041.
Crossref
Crossref
Sharon L Sanders, Sushil Agwan, Mohamed Hassan, Mieke L van Driel & Chris B Del Mar. (2019) Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Xinran Zou, Jing Wu, Jiaqi Gu, Li Shen & Lingxiang Mao. (2019) Application of Aptamers in Virus Detection and Antiviral Therapy. Frontiers in Microbiology 10.
Crossref
Crossref
MengJie MengJie Hu, Keith E Schulze, Reena Ghildyal, Darren C Henstridge, Jacek L Kolanowski, Elizabeth J New, Yuning Hong, Alan C Hsu, Philip M Hansbro, Peter AB Wark, Marie A Bogoyevitch & David Andrew Jans. (2019) Respiratory Syncytial Virus co-opts host mitochondrial function to favour infectious virus production. eLife 8.
Crossref
Crossref
Yaneisi Vázquez, Liliana González, Loreani Noguera, Pablo A. González, Claudia A. Riedel, Pablo Bertrand & Susan M. Bueno. (2019) Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update. Frontiers in Immunology 10.
Crossref
Crossref
Rika Gomi, Anurag Sharma, Wenzhu Wu & Stefan Worgall. (2018) Neonatal Genetic Delivery of Anti-Respiratory Syncytial Virus (RSV) Antibody by Non-Human Primate-Based Adenoviral Vector to Provide Protection against RSV. Vaccines 7:1, pages 3.
Crossref
Crossref
Eun-Jin Choi, Yuping Ren, Yu Chen, Shengxuan Liu, Wenzhe Wu, Junping Ren, Pingyuan Wang, Roberto P. Garofalo, Jia Zhou & Xiaoyong Bao. (2018) Exchange Proteins Directly Activated by cAMP and Their Roles in Respiratory Syncytial Virus Infection. Journal of Virology 92:22.
Crossref
Crossref
Ian Mitchell, S. K. Wong, B. Paes, M. Ruff, C. Bjornson, A. Li & K. L. Lanctôt. (2018) Respiratory syncytial virus prophylaxis in cystic fibrosis: the Canadian registry of palivizumab data (2005–2016). European Journal of Clinical Microbiology & Infectious Diseases 37:7, pages 1345-1352.
Crossref
Crossref
Candice Bjornson, Parco Chan, Abby Li, Bosco Paes, Krista L. Lanctôt & Ian Mitchell. (2018) Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?. European Journal of Clinical Microbiology & Infectious Diseases 37:6, pages 1113-1118.
Crossref
Crossref